Position in PTCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,157,337
+$3,945,183 QoQ
Shares Held
185,820
+12.9% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#67
of 380 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. PTCT ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
This page
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in PTCT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,157,337 | 185,820 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $11,212,154 | 164,570 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,914,732 | 183,185 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,366,192 | 87,440 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,114,770 | 84,250 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,169,202 | 62,190 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $253,686 | 5,620 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $220,745 | 5,950 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | $237,227 | 5,833 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $275,187 | 5,681 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,869,820 | 153,781 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,265,279 | 164,647 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $7,496,427 | 187,130 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,452,372 | 199,742 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,417,396 | 136,013 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,627,212 | 124,354 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,512,890 | 83,106 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,782,967 | 227,729 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $12,504,008 | 204,883 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $43,197 | 924 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $17,809 | 351 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $13,383 | 300 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||